| Literature DB >> 7773578 |
J Mayer1, R Hajek, J Vorlicek, M Tomiska.
Abstract
Mortality from septic shock is considerable despite the advantages of cardiovascular support and antibiotic therapy. This article reviews current therapy of septic shock including immunotherapy and further possibilities of septic shock treatment. The role of cytokines, their inhibitors and antibodies to endotoxin is mentioned. Although these treatments hold much promise for the future, careful evaluation of both the benefits and complications of therapy is needed before widespread clinical use can be recommended.Entities:
Mesh:
Substances:
Year: 1995 PMID: 7773578 DOI: 10.1007/bf00365850
Source DB: PubMed Journal: Support Care Cancer ISSN: 0941-4355 Impact factor: 3.603